ProfileGDS4718 / 210014_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 95% 92% 92% 94% 92% 96% 94% 94% 92% 94% 94% 91% 94% 98% 93% 94% 95% 89% 96% 80% 95% 95% 94% 95% 93% 97% 93% 94% 93% 95% 88% 97% 91% 93% 93% 96% 86% 92% 94% 93% 94% 88% 95% 94% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.435795
GSM549102patient 115, normal, homogenized [OPG study]9.6475892
GSM549104patient 119, normal, homogenized [OPG study]9.6921292
GSM549108patient 138, normal, homogenized [OPG study]9.8567394
GSM549119patient 077, normal, homogenized [OPG study]9.5538492
GSM549133patient 032, cancer, homogenized [OPG study]10.412996
GSM549139patient 042, cancer, homogenized [OPG study]9.9999994
GSM549099patient 107, normal, homogenized [OPG study]9.844194
GSM549109patient 139, normal, homogenized [OPG study]9.6324292
GSM549110patient 046, normal, homogenized [OPG study]10.052294
GSM549114patient 063, normal, homogenized [OPG study]10.281694
GSM549122patient 082, normal, homogenized [OPG study]9.4335191
GSM549134patient 033, cancer, homogenized [OPG study]9.9483894
GSM549136patient 036, cancer, homogenized [OPG study]11.379198
GSM549140patient 044, cancer, homogenized [OPG study]9.86193
GSM549111patient 047, normal, homogenized [OPG study]10.086794
GSM549113patient 057, normal, homogenized [OPG study]10.337795
GSM549132patient 031, cancer, homogenized [OPG study]9.0150389
GSM549137patient 038, cancer, homogenized [OPG study]10.327196
GSM549142patient 047, cancer, homogenized [OPG study]7.6499780
GSM549100patient 110, normal, homogenized [OPG study]10.142395
GSM549107patient 135, normal, homogenized [OPG study]10.233995
GSM549115patient 068, normal, homogenized [OPG study]10.142994
GSM549116patient 072, normal, homogenized [OPG study]10.224995
GSM549120patient 078, normal, homogenized [OPG study]9.9128293
GSM549131patient 030, cancer, homogenized [OPG study]10.952697
GSM549118patient 074, normal, homogenized [OPG study]9.8710193
GSM549129patient 027, cancer, homogenized [OPG study]9.8806894
GSM549123patient 088, normal, homogenized [OPG study]9.9267193
GSM549124patient 006, cancer, homogenized [OPG study]10.003695
GSM549126patient 015, cancer, homogenized [OPG study]8.8811488
GSM549128patient 025, cancer, homogenized [OPG study]11.076997
GSM549103patient 117, normal, homogenized [OPG study]9.2408291
GSM549117patient 073, normal, homogenized [OPG study]9.9310993
GSM549138patient 041, cancer, homogenized [OPG study]9.7566893
GSM549141patient 045, cancer, homogenized [OPG study]10.427496
GSM549130patient 028, cancer, homogenized [OPG study]8.4594186
GSM549101patient 111, normal, homogenized [OPG study]9.4282492
GSM549105patient 128, normal, homogenized [OPG study]9.9055194
GSM549106patient 134, normal, homogenized [OPG study]9.9790593
GSM549112patient 048, normal, homogenized [OPG study]10.147394
GSM549125patient 011, cancer, homogenized [OPG study]8.8653388
GSM549127patient 024, cancer, homogenized [OPG study]10.017195
GSM549135patient 035, cancer, homogenized [OPG study]10.002894